Medicamen Biotech P/E Ratio

Current P/E Ratio
33.37
High Valuation
Very High - High growth expectations or significantly overvalued

Medicamen Biotech (MEDICAMEQ) P/E ratio is 33.37 (High), EPS (TTM) ₹7.22, current price ₹241.85 on NSE vs historical average P/E of 74.05 (14.3th percentile) — Very High - High growth expectations or significantly overvalued. See MEDICAMEQ price book multiple to compare market price against book value per share.

Current Valuation Metrics

P/E Ratio 33.37
Current Price ₹241.85
EPS (TTM) ₹7.22
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 74.05
Historical Range 30.93 - 112.62
Percentile 14.3%

Sector Context

Sector Average 55.76
Sector Median 31.4
Sector Rank #11 of 194
Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹7.49
Mar 2026 ₹3.28
Sept 2025 ₹1.56

MEDICAMEQ P/E Ratio — Valuation Signal & Historical Context

Medicamen Biotech P/E 33.37 vs historical average 74.05, range 30.93–112.62 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Medicamen Biotech share price today.

  • Stock appears overvalued with PE of 33.37, suggesting caution for new investments
  • Current PE is 54.9% below historical average
  • Trading at discount to sector average PE of 55.76

Medicamen Biotech P/E Ratio Historical Trend

MEDICAMEQ annual price-to-earnings ratio — 7 years, EPS and year-end price. Current P/E 33.37 vs historical average 74.05. Read MEDICAMEQ dividend growth for the complete payout history and dividend yield track record.

MEDICAMEQ Historical P/E Ratio — EPS, Year-End Price & Valuation

Medicamen Biotech annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 93.21 5.42 ₹505.20 NSE High
2024 112.62 5.25 ₹591.25 NSE High
2023 97.16 8.92 ₹866.70 NSE High
2022 88.94 11.02 ₹980.10 NSE High
2021 42.66 12.94 ₹552.00 NSE High
2020 52.86 9.0 ₹475.75 BSE High
2019 30.93 11.04 ₹341.50 BSE High

MEDICAMEQ vs Healthcare Peers — P/E Ratio Comparison

Medicamen Biotech P/E 33.37 vs Healthcare average 55.76, median 31.4 — range 2.86–916.67.

Sector Average
55.76
Sector Median
31.4
Lowest P/E
2.86
Highest P/E
916.67
Companies
194
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.61 ₹64 Low
Sunrest Lifescience SUNREST 3.76 ₹30 Low
Sun Pharma Advanced Rese… SPARC 4.76 ₹7,399 Low
Shelter Pharma SHELTER 5.23 ₹47 Low
Dipna Pharmachem DPL 5.39 ₹14 Low
JFL Life Sciences JFLLIFE 5.41 ₹68 Low
Amwill Health Care AMWILL 7.26 ₹83 Low
Zenith Drugs ZENITHDRUG 7.69 ₹84 Low
Galaxy Medicare GML 7.8 ₹27 Low